Structural basis for the inhibition ofMycobacterium tuberculosisL,D-transpeptidase by meropenem, a drug effective against extensively drug-resistant strains
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structural basis for the inhibition ofMycobacterium tuberculosisL,D-transpeptidase by meropenem, a drug effective against extensively drug-resistant strains
Authors
Keywords
-
Journal
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
Volume 69, Issue 3, Pages 420-431
Publisher
International Union of Crystallography (IUCr)
Online
2013-02-16
DOI
10.1107/s0907444912048998
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Kinetic Analysis of Enterococcus faecium l,d-Transpeptidase Inactivation by Carbapenems
- (2012) Vincent Dubée et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Meropenem-Clavulanic Acid Shows Activity against Mycobacterium tuberculosis In Vivo
- (2012) Kathleen England et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inactivation of Mycobacterium tuberculosis l,d-Transpeptidase LdtMt1by Carbapenems and Cephalosporins
- (2012) Vincent Dubée et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Leptospiral Immunoglobulin-like Proteins Interact With Human Complement Regulators Factor H, FHL-1, FHR-1, and C4BP
- (2012) Mónica Marcela Castiblanco-Valencia et al. JOURNAL OF INFECTIOUS DISEASES
- Putting a Stop to l,d-Transpeptidases
- (2012) Soumya De et al. STRUCTURE
- Dynamics Induced by β-Lactam Antibiotics in the Active Site of Bacillus subtilis l,d-Transpeptidase
- (2012) Lauriane Lecoq et al. STRUCTURE
- Targeting the Cell Wall of Mycobacterium tuberculosis: Structure and Mechanism of L,D-Transpeptidase 2
- (2012) Sabri B. Erdemli et al. STRUCTURE
- REFMAC5 for the refinement of macromolecular crystal structures
- (2011) Garib N. Murshudov et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Activity of Carbapenems Combined with Clavulanate against Murine Tuberculosis
- (2011) Nicolas Veziris et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs
- (2011) P. E. Almeida Da Silva et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- The Mycobacterium tuberculosis protein LdtMt2 is a nonclassical transpeptidase required for virulence and resistance to amoxicillin
- (2010) Radhika Gupta et al. NATURE MEDICINE
- Dali server: conservation mapping in 3D
- (2010) Liisa Holm et al. NUCLEIC ACIDS RESEARCH
- Big Domains Are Novel Ca2+-Binding Modules: Evidences from Big Domains of Leptospira Immunoglobulin-Like (Lig) Proteins
- (2010) Rajeev Raman et al. PLoS One
- Drug-resistant tuberculosis: Past, present, future
- (2010) Chen-Yuan CHIANG et al. RESPIROLOGY
- The Population Dynamics and Control of Tuberculosis
- (2010) C. Dye et al. SCIENCE
- Molecular replacement withMOLREP
- (2009) Alexei Vagin et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- MolProbity: all-atom structure validation for macromolecular crystallography
- (2009) Vincent B. Chen et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis
- (2009) J.-E. Hugonnet et al. SCIENCE
- The Peptidoglycan of Stationary-Phase Mycobacterium tuberculosis Predominantly Contains Cross-Links Generated by L,D-Transpeptidation
- (2008) M. Lavollay et al. JOURNAL OF BACTERIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started